The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. China National Medicines's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for China National Medicines's Dividend Payout Ratio or its related term are showing as below:
SHSE:600511'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09 Med: 0.27 Max: 0.37
Current: 0.29
During the past 13 years, the highest Dividend Payout Ratio of China National Medicines was 0.37. The lowest was 0.09. And the median was 0.27.
SHSE:600511's Dividend Payout Ratio is ranked better than 65.57% of 61
companies
in the Medical Distribution industry
Industry Median: 0.43
vs SHSE:600511: 0.29
During the past 13 years, the highest Trailing Annual Dividend Yield of China National Medicines was 3.11%. The lowest was 0.28%. And the median was 1.85%.
During the past 12 months, China National Medicines's average Dividends Per Share Growth Rate was -6.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 4.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 7.60% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 24.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of China National Medicines was 67.40% per year. The lowest was -26.30% per year. And the median was 17.20% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
China National Medicines (SHSE:600511) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
China National Medicines Dividend Payout Ratio Related Terms
China National Medicines Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for China National Medicines's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Medicines Dividend Payout Ratio Chart
SHSE:600511 vs MCK, CAH, COR: Dividend Payout Ratio Comparison
For the Medical Distribution subindustry, China National Medicines's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Medicines Dividend Payout Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Medicines's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where China National Medicines's Dividend Payout Ratio falls into.
China National Medicines Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
China National Medicines's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Medicines (SHSE:600511) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China National Medicines and its competitors. Over the past decade, China National Medicines' Dividend Payout Ratio has ranged from 0.09 to 0.37. According to the industry distribution chart, China National Medicines ranks #21 out of 61 companies in the Medical Distribution industry, placing it in the top 34.4%.
Is China National Medicines' Dividend Payout Ratio too high?
China National Medicines' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.37. Based on the distribution chart, China National Medicines ranks #21 out of 61 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China National Medicines has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Medicines' Dividend Payout Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, China National Medicines ranks #21 out of 61 companies for Dividend Payout Ratio. This puts China National Medicines in the upper half of its industry. The industry median Dividend Payout Ratio is 0.43. Historically, China National Medicines' own Dividend Payout Ratio has ranged from 0.09 to 0.37 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Distribution company?
The median Dividend Payout Ratio among Medical Distribution companies is 0.43, based on 61 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China National Medicines and its competitors. For the Medical Distribution industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Medicines's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Medicines (SHSE:600511) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥32.74, compared to a current price of ¥26.94 — trading 17.7% below its estimated fair value. The current Dividend Payout Ratio is 0.00. China National Medicines' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For China National Medicines (SHSE:600511), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China National Medicines (SHSE:600511) Overvalued in 2026?
Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued.
The current stock price of ¥26.94 is trading 17.7% below its estimated GF Value™ of ¥32.74.
GuruFocus considers China National Medicines to be Modestly Undervalued.
Key valuation signals for SHSE:600511:
Dividend Payout Ratio: 0.00
GF Value™: ¥32.74 vs. price of ¥26.94 (17.7% below fair value)
No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
86GF Score
Get the complete analysis for SHSE:600511
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600511 has been successfully added to your 
